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[Abstract] This protocol details the extraction of microsomes from frozen tissue in order to further 
examine the protein-protein interactions occurring within the endoplasmic reticulum. This protocol 
was adapted from Abisambra et al. (2013) with modifications made in order to optimize for 
subsequent use. 
 
Materials and Reagents 
 
1. Sucrose  
2. Protease Inhibitor cocktail, EDTA free (Merck KGaA, Calbiochem, catalog number: 
539134) 
3. Phosphatase inhibitor cocktail II 
4. Phosphatase inhibitor cocktail III 
5. PMSF at 10 mM in DMSO or 1.74 mg/ml (Thermo Fisher Scientific, catalog number: 
36978) 
6. Phosphatase Arrest II cocktail (Geno Technology,  catalog number: 786-451) 
7. Phosphatase Arrest III cocktail (Geno Technology, catalog number: 786-452) 
8. M-PER Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, catalog 
number: 78501) 
 
Equipment 
 
1. Sterile bottle filter 
2. Glass Dounce homogenizer 
3. Refrigerated centrifuge 
4. Microfuge tubes rated for at least 25,000 x g centrifugation  
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Procedure 
 
1. Make a 0.25 M sucrose solution that contains protease inhibitor cocktail, phosphatase 
inhibitor cocktails II and III, and PMSF as follows: 
Per 100 μl of Sucrose master mix add: 
a. 96 μl of 0.25 M sucrose 
b. 1 μl of protease inhibitor cocktail 
c. 1 μl of phosphatase inhibitor cocktail II 
d. 1 μl of phosphatase inhibitor cocktail III 
e. 1 μl of PMSF 
2. Weigh tissue to be analyzed and add 10x its mass in volume of sucrose master mix (see 
step 1; i.e. 100 mg = 1,000 μl of sucrose solution). 
3. While keeping all solutions on ice, add the appropriate amount of sucrose solution to 
tissue and dounce homogenize until a completely homogenous solution is obtained. 
4. Spin the homogenate at 10,000 x g for 10 min at 4 °C. 
5. Transfer the supernatants to a new microfuge tube (save the pellet at -20 °C) and spin at 
30,000 x g for 90 min in a fixed angle rotor (or at 25,800 x g for 2 h). 
6. Transfer the supernatant to a different microfuge tube and save at -20 °C. The remaining 
pellet corresponds to the microsomal fraction. 
7. Pipette gently to resuspend the microsome pellet in 200 μl of the following mix (per 100 
μl): 
a. 96 μl of MPER buffer 
b. 1 μl of protease inhibitor cocktail 
c. 1 μl of phosphatase arrest cocktail II 
d. 1 μl of phosphatase arrest cocktail III 
e. 1 μl of PMSF 
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